AI Verdict
KZR has stronger fundamentals based on our AI analysis.
LAB vs KZR Fundamental Comparison
| Metric | LAB | KZR |
|---|---|---|
| Revenue | $85.3M | $0.0 |
| Net Income | $-74.9M | $-56.0M |
| Net Margin | -87.8% | N/A |
| ROE | -17.7% | -80.0% |
| ROA | -13.2% | -73.1% |
| Current Ratio | 4.19x | 11.52x |
| Debt/Equity | 0.00x | 0.00x |
| EPS | $-0.20 | $-7.66 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
LAB vs KZR: Frequently Asked Questions
Is LAB or KZR a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), KZR has stronger fundamentals. LAB is rated STRONG SELL (88% confidence) while KZR is rated HOLD (68% confidence). This is not investment advice.
How does LAB compare to KZR fundamentally?
STANDARD BIOTOOLS INC. has ROE of -17.7% vs Kezar Life Sciences, Inc.'s -80.0%. Net margins are -87.8% vs N/A respectively.
Which stock pays higher dividends, LAB or KZR?
LAB has a dividend yield of N/A or no dividend while KZR has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in LAB or KZR for long term?
For long-term investing, consider that LAB has STRONG SELL rating with 88% confidence, while KZR has HOLD rating with 68% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about LAB vs KZR?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For LAB vs KZR, the AI consensus favors KZR based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.